Skip to Main Content

Paper Details

RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.
Cancer Res
18
2021
AMPC, AR, AR-negative, ASCL1, CRPC, CRPC cell lines, Castration-Resistant Neuroendocrine Prostate Cancer, LuCaP patient-derived xenograft models, NE, NE-positive amphicrine prostate cancer, RE1-silencing transcription factor, REST, REST locus, REST repressor, REST splicing factor, REST-repressed genes, REST4, RNA Splicing, SCNPC, SRRM3, SRRM4, SRRM4-negative AMPC, androgen, androgen receptor, androgen receptor (AR)-positive NE, arginine, mCRPC, metastatic castration-resistant prostate cancer, neuronal genes, patient, prostate cancer, prostate cancer cell lines, serine, serine/arginine repetitive matrix protein 4, small cell or neuroendocrine prostate cancer, tumor
Author NameAffiliation
Ilsa ColemanFred Hutchinson Cancer Research Center
Ilsa ColemanDivison of Clinical Research, Fred Hutchinson Cancer Research Center
Michael C HaffnerFred Hutchinson Cancer Research Center
Michael C HaffnerDivison of Clinical Research, Fred Hutchinson Cancer Research Center
Michael C HaffnerUniversity of Washington
David S Rickman
Lawrence D TrueUniversity of Washington
Lawrence D TrueUniversity of Washington
Daniel W LinUniversity of Washington
Daniel W LinFred Hutchinson Cancer Research Center
Joshi J AlumkalRogel Cancer Center, University of Michigan ann arbor
Eva CoreyUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonDivison of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonDivison of Clinical Research, Fred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Colm MorrisseyUniversity of Washington
  • 1 - 19

Datasets

Release 1.2